O'Neill, James B
Director
Disclosed trades
0
Purchases (all, mid $)
$0
Sales (all, mid $)
$0
Disclosed assets
31
Assets & income
Everything disclosed across this official's filings
showing 31 of 31 matching rows — search reaches all 31
| Official | Asset | Value (band) | Mid $ ▼ | Income type | Processed (UTC) |
|---|---|---|---|---|---|
| O'Neill, James B | Schwab S&P 500 Index Fund (SWPPX) | $100,001 - $250,000 | $175K | – | 2026-07-18 17:07 |
| O'Neill, James B | Schwab S&P 500 Index Fund (SWPPX) | $100,001 - $250,000 | $175K | – | 2026-07-25 02:08 |
| O'Neill, James B | ADvantage Therapeutics, Inc., anticipated bonus | $50,001 - $100,000 | $75K | – | 2026-07-18 17:07 |
| O'Neill, James B | ADvantage Therapeutics, Inc., advisor fees: cash receivable | $15,001 - $50,000 | $33K | – | 2026-07-18 17:07 |
| O'Neill, James B | ADvantage Therapeutics, Inc., unvested stock options | $15,001 - $50,000 | $33K | – | 2026-07-18 17:07 |
| O'Neill, James B | Rational Vaccines, Inc. (herpes vaccines development), consulting fees: cash receivable | $15,001 - $50,000 | $33K | – | 2026-07-18 17:07 |
| O'Neill, James B | U.S. brokerage accounts (cash) | $15,001 - $50,000 | $33K | – | 2026-07-18 17:07 |
| O'Neill, James B | U.S. bank (cash) | $15,001 - $50,000 | $33K | – | 2026-07-18 17:07 |
| O'Neill, James B | U.S. brokerage account (cash) | $15,001 - $50,000 | $33K | – | 2026-07-25 02:08 |
| O'Neill, James B | U.S. bank (cash) | $15,001 - $50,000 | $33K | – | 2026-07-25 02:08 |
| O'Neill, James B | Arcadia Medicine, Inc., consulting fees: cash receivable | $1,001 - $15,000 | $8K | – | 2026-07-18 17:07 |
| O'Neill, James B | ADvantage Therapeutics, Inc., vested stock options | $1,001 - $15,000 | $8K | – | 2026-07-18 17:07 |
| O'Neill, James B | USAA Universal Life Insurance | $1,001 - $15,000 | $8K | – | 2026-07-18 17:07 |
| O'Neill, James B | USAA Universal Life Insurance | $1,001 - $15,000 | $8K | – | 2026-07-25 02:08 |
| O'Neill, James B | Bitcoin | $0 - $1,000 | $500 | – | 2026-07-18 17:07 |
| O'Neill, James B | Bitcoin | $0 - $1,000 | $500 | – | 2026-07-18 17:07 |
| O'Neill, James B | ADvantage Therapeutics, stock | $0 - $1,000 | $500 | Capital Gains | 2026-07-25 02:08 |
| O'Neill, James B | Bitcoin | $0 - $1,000 | $500 | – | 2026-07-25 02:08 |
| O'Neill, James B | Bitcoin | $0 - $1,000 | $500 | – | 2026-07-25 02:08 |
| O'Neill, James B | Arcadia Medicine, Inc. (mental health therapeutics) | – | – | Consulting Fees | 2026-07-18 17:07 |
| O'Neill, James B | ADvantage Therapeutics, Inc. (neurodegenerative therapeutics) | – | – | Board of Directors Fee | 2026-07-18 17:07 |
| O'Neill, James B | ADvantage Therapeutics, Inc. | – | – | Advisor Fees | 2026-07-18 17:07 |
| O'Neill, James B | Noots, Inc. (nootropic supplements), stock options (value not readily ascertainable): 12,500 vested shares, strike $0.01 | – | – | – | 2026-07-18 17:07 |
| O'Neill, James B | Roth IRA | – | – | – | 2026-07-18 17:07 |
| O'Neill, James B | Coinbase account | – | – | – | 2026-07-18 17:07 |
| O'Neill, James B | U.S. brokerage account | – | – | – | 2026-07-18 17:07 |
| O'Neill, James B | Arcadia Medicine, Inc. (Mental health therapeutics) | – | – | Consulting Fees | 2026-07-25 02:08 |
| O'Neill, James B | ADvantage Therapeutics (Neurodegenerative Therapeutics) | – | – | Advisor fees | 2026-07-25 02:08 |
| O'Neill, James B | Roth IRA | – | – | – | 2026-07-25 02:08 |
| O'Neill, James B | Coinbase account | – | – | – | 2026-07-25 02:08 |
| O'Neill, James B | U.S. brokerage account | – | – | – | 2026-07-25 02:08 |
Positions held outside government
showing 22 of 22 matching rows — search reaches all 22
| Official ▲ | Organization | Position | Org type | From | To | Processed (UTC) |
|---|---|---|---|---|---|---|
| O'Neill, James B | California Institute for Machine Consciousness | Treasurer | Non-Profit | 8/2024 | Present | 2026-07-18 17:07 |
| O'Neill, James B | California Institute for Machine Consciousness | Member, Board of Directors | Non-Profit | 8/2024 | Present | 2026-07-18 17:07 |
| O'Neill, James B | Arcadia Medicine, Inc. | Advisor | Corporation | 4/2024 | Present | 2026-07-18 17:07 |
| O'Neill, James B | ADvantage Therapeutics, Inc. | Member, Board of Directors | Corporation | 3/2023 | Present | 2026-07-18 17:07 |
| O'Neill, James B | ADvantage Therapeutics, Inc. | Advisor | Corporation | 1/2023 | Present | 2026-07-18 17:07 |
| O'Neill, James B | Klothea Bio, Inc. (wholly owned subsidiary of ADvantage Therapeutics, Inc.) | Member, Board of Directors | Corporation | 9/2024 | 10/2024 | 2026-07-18 17:07 |
| O'Neill, James B | Rational Vaccines, Inc. | Global Health Advisor | Corporation | 1/2022 | Present | 2026-07-18 17:07 |
| O'Neill, James B | Noots, Inc. | Advisor | Corporation | 11/2021 | Present | 2026-07-18 17:07 |
| O'Neill, James B | Very Liquid Co. | Advisor | Corporation | 3/2024 | 3/2025 | 2026-07-18 17:07 |
| O'Neill, James B | Trump Vance 2025 Transition, Inc. | Policy Volunteer | Non-Profit | 11/2024 | 1/2025 | 2026-07-18 17:07 |
| O'Neill, James B | Seasteading Institute | Member, Board of Directors | Non-Profit | 12/2011 | 3/2024 | 2026-07-18 17:07 |
| O'Neill, James B | California Institute for Machine Consciousness | Treasurer | Non-Profit | 8/2024 | 6/2025 | 2026-07-25 02:08 |
| O'Neill, James B | California Institute for Machine Consciousness | Member, Board of Directors | Non-Profit | 8/2024 | 6/2025 | 2026-07-25 02:08 |
| O'Neill, James B | Arcadia Medicine, Inc. | Advisor | Corporation | 4/2024 | 6/2025 | 2026-07-25 02:08 |
| O'Neill, James B | ADvantage Therapeutics, Inc. | Member, Board of Directors | Corporation | 3/2023 | 6/2025 | 2026-07-25 02:08 |
| O'Neill, James B | ADvantage Therapeutics, Inc. | Advisor | Corporation | 1/2023 | 6/2025 | 2026-07-25 02:08 |
| O'Neill, James B | Klothea Bio, Inc. (wholly owned subsidiary of ADvantage Therapeutics, Inc.) | Member, Board of Directors | Corporation | 9/2024 | 10/2024 | 2026-07-25 02:08 |
| O'Neill, James B | Rational Vaccines, Inc. | Global Health Advisor | Corporation | 1/2022 | 6/2025 | 2026-07-25 02:08 |
| O'Neill, James B | Noots, Inc. | Advisor | Corporation | 11/2021 | 6/2025 | 2026-07-25 02:08 |
| O'Neill, James B | Very Liquid Co. | Advisor | Corporation | 3/2024 | 3/2025 | 2026-07-25 02:08 |
| O'Neill, James B | Trump Vance 2025 Transition, Inc. | Policy Volunteer | Non-Profit | 11/2024 | 1/2025 | 2026-07-25 02:08 |
| O'Neill, James B | Seasteading Institute | Member, Board of Directors | Non-Profit | 12/2011 | 3/2024 | 2026-07-25 02:08 |
Employment agreements & arrangements
showing 5 of 5 matching rows — search reaches all 5
| Official ▲ | Employer / party | Status & terms | Date | Processed (UTC) |
|---|---|---|---|---|
| O'Neill, James B | ADvantage Therapeutics, Inc. | Pursuant to past practice, I am eligible to receive discretionary bonuses based on my 2023 and 2024 performance. If ADvantage Therapeutics, Inc., decides to pay me bonuses for work I performed during 2023 and 2024, I will receive the bonuses prior to assuming my duties or I will forfeit the bonuses. | 12/2023 | 2026-07-18 17:07 |
| O'Neill, James B | ADvantage Therapeutics, Inc. | I will forfeit my unvested stock options upon separation. I have 90 days after separation to exercise my vested stock options. I will divest my vested stock options within 90 days of confirmation. If I divest my vested stock options by exercising them, I will divest the resulting stock within 90 days of confirmation. | 3/2023 | 2026-07-18 17:07 |
| O'Neill, James B | ADvantage Therapeutics, Inc. | In April 2025, I will receive advisor fees owed to me for services previously performed. | 1/2023 | 2026-07-18 17:07 |
| O'Neill, James B | Rational Vaccines, Inc. | In April 2025, I will receive consulting fees owed to me for services previously performed. | 1/2022 | 2026-07-18 17:07 |
| O'Neill, James B | Noots, Inc. | I will divest my vested stock options within 90 days of confirmation. If I divest my vested stock options by exercising them, I will divest the resulting stock within 90 days of confirmation. | 11/2021 | 2026-07-18 17:07 |
Source: U.S. Office of Government Ethics (public financial disclosure reports). Officials disclose amounts as ranges; dollar figures use range midpoints. Figures are informational estimates and may contain extraction errors. Nothing here is investment advice or an accusation of wrongdoing.